These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9105692)
1. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition. Fujitani S; Okazaki K; Yada T Br J Pharmacol; 1997 Apr; 120(7):1191-8. PubMed ID: 9105692 [TBL] [Abstract][Full Text] [Related]
2. A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx. Fujitani S; Yada T Endocrinology; 1994 Mar; 134(3):1395-400. PubMed ID: 8119179 [TBL] [Abstract][Full Text] [Related]
3. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide. Hashiguchi S; Yada T; Arima T J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358 [TBL] [Abstract][Full Text] [Related]
4. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride. Müller G; Korndörfer A; Kornak U; Malaisse WJ Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478 [TBL] [Abstract][Full Text] [Related]
5. Glucose and tolbutamide trigger transients of Ca2+ in single pancreatic beta-cells exposed to tetraethylammonium. Eberhardson M; Grapengiesser E Cell Calcium; 1999 May; 25(5):355-60. PubMed ID: 10463099 [TBL] [Abstract][Full Text] [Related]
6. Glucose metabolism by rat pancreatic beta-cells produces dual change in cytosolic Ca2+. Yada T; Itoh K; Kakei M; Tanaka H Jpn J Physiol; 1993; 43 Suppl 1():S115-8. PubMed ID: 8271483 [TBL] [Abstract][Full Text] [Related]
7. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells. Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827 [TBL] [Abstract][Full Text] [Related]
8. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166). Ikenoue T; Akiyoshi M; Fujitani S; Okazaki K; Kondo N; Maki T Br J Pharmacol; 1997 Jan; 120(1):137-45. PubMed ID: 9117089 [TBL] [Abstract][Full Text] [Related]
9. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells. Best L; Benington S Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927 [TBL] [Abstract][Full Text] [Related]
10. Sulfonylurea mimics the effect of glucose in inducing large amplitude oscillations of cytoplasmic Ca2+ in pancreatic beta-cells. Grapengiesser E; Gylfe E; Hellman B Mol Pharmacol; 1990 Mar; 37(3):461-7. PubMed ID: 2179710 [TBL] [Abstract][Full Text] [Related]
11. Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria. Grimmsmann T; Rustenbeck I Br J Pharmacol; 1998 Mar; 123(5):781-8. PubMed ID: 9535004 [TBL] [Abstract][Full Text] [Related]
12. Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas. Fujitani S; Ikenoue T; Akiyoshi M; Maki T; Yada T Metabolism; 1996 Feb; 45(2):184-9. PubMed ID: 8596487 [TBL] [Abstract][Full Text] [Related]
13. cAMP-signaling pathway acts in selective synergism with glucose or tolbutamide to increase cytosolic Ca2+ in rat pancreatic beta-cells. Yaekura K; Kakei M; Yada T Diabetes; 1996 Mar; 45(3):295-301. PubMed ID: 8593933 [TBL] [Abstract][Full Text] [Related]
14. Repetitive mitochondrial Ca2+ signals synchronize with cytosolic Ca2+ oscillations in the pancreatic beta-cell line, MIN6. Nakazaki M; Ishihara H; Kakei M; Inukai K; Asano T; Miyazaki JI; Tanaka H; Kikuchi M; Yada T; Oka Y Diabetologia; 1998 Mar; 41(3):279-86. PubMed ID: 9541167 [TBL] [Abstract][Full Text] [Related]
15. Does glucose decrease cytosolic free calcium in normal pancreatic islet cells? Gobbe P; Herchuelz A Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):231-47. PubMed ID: 2652230 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of mitochondrial function affects cellular Ca2+ handling in pancreatic B-cells. Düfer M; Krippeit-Drews P; Drews G Pflugers Arch; 2002 May; 444(1-2):236-43. PubMed ID: 11976937 [TBL] [Abstract][Full Text] [Related]
17. A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells. Akiyoshi M; Kakei M; Nakazaki M; Tanaka H Am J Physiol; 1995 Feb; 268(2 Pt 1):E185-93. PubMed ID: 7864093 [TBL] [Abstract][Full Text] [Related]
18. Effects of gliquidone on D-glucose metabolism in rat pancreatic islets depend on hexose concentration. Picton S; Malaisse-Lagae F; Malaisse WJ Res Commun Mol Pathol Pharmacol; 1998 Nov; 102(2):99-112. PubMed ID: 10100502 [TBL] [Abstract][Full Text] [Related]
19. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment. Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725 [TBL] [Abstract][Full Text] [Related]
20. Effects of tolbutamide and N-benzoyl-D-phenylalanine (NBDP) on the regulation of [Ca2+]i oscillations in mouse pancreatic islets. Lenzen S; Peckmann T Biochem Pharmacol; 2001 Oct; 62(7):923-8. PubMed ID: 11543727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]